LUXZYLA
DEAD

Serial Number

90674894

Owner

Cycle Pharmaceuticals Ltd.

Attorney

Mary Frances Love

Filing Date

Apr 27, 2021

Add to watchlist:

No watchlists yet
View on USPTO

LUXZYLA Trademark

Serial Number: 90674894

LUXZYLA is a trademark filed by Cycle Pharmaceuticals Ltd. on April 27, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Cycle Pharmaceuticals Ltd. (23 trademarks)

The Broers Building,

Entity Type: 99

Trademark Details

Filing Date

April 27, 2021

Registration Date

Not Registered

Published for Opposition

October 24, 2023

Goods & Services

Pharmaceutical agents for the treatment of disorders of the metabolism and digestive system; pharmaceutical agents for the treatment of lysosomal storage disorders and lysosomal storage diseases; pharmaceutical agents for the treatment of lysosomal storage disorders and lysosomal storage diseases all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceutical agents for the treatment of Wilson's Disease; pharmaceutical agents for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceutical preparations for the treatment of disorders of the metabolism and digestive system; pharmaceutical preparations for the treatment of lysosomal storage disorders and lysosomal storage diseases; pharmaceutical preparations for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceutical preparations for the treatment of Wilson's Disease; pharmaceutical preparations for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceuticals for the treatment of disorders of the metabolism and digestive system, pharmaceuticals for the treatment of lysosomal storage disorders and lysosomal storage diseases; pharmaceuticals for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceuticals for the treatment of Wilson's Disease; pharmaceuticals for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Veterinary pharmaceutical preparations for treatment of disorders of the metabolism and digestive system; veterinary pharmaceutical preparations, namely, antioxidants; Veterinary pharmaceutical preparations, namely, pain relief medications; Veterinary pharmaceutical preparations for treatment of chronic illnesses; Veterinary pharmaceutical preparations for treatment of viral diseases; sanitary preparations for medical purposes; dietetic foods adapted for medical or veterinary use; dietary supplements for humans and animals supplements for the treatment of disorders of the metabolism and digestive system; Dietary supplements for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibles, vapors, gases, mists, creams, gels and patches; Dietary supplements for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; food for babies; medical dressings; plasters for medical purposes; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; biological preparations for the treatment of disorders of the metabolism and digestive system; biological preparations for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; biological preparations for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; chemical preparations for medical purposes, namely, for the treatment of disorders of the metabolism and digestive system; chemical preparations for medical purposes, namely, for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibles, vapors, gases, mists, creams, gels and patches; chemical preparations for medical purposes, namely, for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches for use in pharmaceuticals; drug delivery agents in the form of capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches for use in the treatment of disorders of the metabolism and digestive system; drug delivery agents in the form of capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches for use in the treatment of lysosomal storage disorders and lysosomal storage diseases; drug delivery agents in the form of capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches for use in the treatment of Wilson's Disease; Pharmaceutical preparations in the form of drugs and medicines for the treatment of disorders of the metabolism and digestive system; Pharmaceutical preparations in the form drugs and medicines for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibles, vapors, gases, mists, creams, gels and patches; Pharmaceutical preparations in the form drugs and medicines for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Pharmaceutical preparations in the form of drugs for the treatment of rare diseases, in particular for the treatment of disorders of the metabolism and digestive system; Pharmaceutical preparations in the form of drugs for the treatment of rare diseases, in particular for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Pharmaceutical preparations in the form of drugs for the treatment of rare diseases, in particular for Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibles, vapors, gases, mists, creams, gels and patches; enzyme preparations for medical purposes; enzyme preparations for medical purposes for the treatment of disorders of the metabolism and digestive system; enzyme preparations for medical purposes the treatment of lysosomal storage disorders and lysosomal storage diseases; enzyme preparations for medical purposes the treatment of Wilson's Disease; medical enzyme preparations for medical purposes in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; enzyme preparations for veterinary purposes; medical preparations for the treatment of disorders of the metabolism and digestive systems; medical preparations for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; medical preparations for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; medical preparations for the treatment of disorders of the metabolism and digestive system, medicines for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches medicines for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 22, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 22, 2024 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 19, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 24, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 24, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 4, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 19, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 22, 2023 CRFA
ASSIGNED TO LIE
Aug 21, 2023 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 7, 2023 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 7, 2022 GNFN
FINAL REFUSAL E-MAILED
Oct 7, 2022 GNFR
FINAL REFUSAL WRITTEN
Oct 7, 2022 CNFR
ASSIGNED TO EXAMINER
Jul 11, 2022 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 30, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 30, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 30, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 30, 2021 GNRN
NON-FINAL ACTION E-MAILED
Dec 30, 2021 GNRT
NON-FINAL ACTION WRITTEN
Dec 30, 2021 CNRT
ASSIGNED TO EXAMINER
Dec 17, 2021 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 5, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 5, 2021 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 5, 2021 COAR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 3, 2021 NWOS
NEW APPLICATION ENTERED
Apr 30, 2021 NWAP